JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB254454

Pexidartinib, CSF1R inhibitor

Be the first to review this product! 리뷰 제출

|

(0 출판물)

MW 417.8 Da, Purity >98%. Potent MCSF Receptor (CSF1R) inhibitor (IC50 = 13 nM). Also inhibits Kit (IC50 = 16 nM) and Flt3 (IC50 = 160 nM). Highly selective (IC50 >1 μM) against a panel of over 200 kinases. Inhibits MCSF Receptor-dependent proliferation (0.1 - 0.44 μM) in cell models. Inhibits glioblastoma invasion in mouse xenograft models.

대체 명칭 보기

AAK1_HUMAN, AP2 associated kinase 1, AP2-associated protein kinase 1, Adaptor-associated kinase 1, C-FMS, CD 115, CD 135, CD115 antigen, CD135 antigen, CSF-1 receptor, CSF1R_HUMAN, CSFR, Colony stimulating factor 1 receptor, Colony stimulating factor I receptor, DKFZp686F03202, DKFZp686K16132, EC 2.7.10.1, FIM 2, FL cytokine receptor, FLJ23712, FLJ25931, FLJ31060, FLJ42882, FLJ45252, FLT3_HUMAN, FMS, FMS proto oncogene, Fetal liver kinase 2, Flk 2, Fms related tyrosine kinase 3, Fms-like tyrosine kinase 3, Growth factor receptor tyrosine kinase type III, HDLS, KIAA1048, KPCT_HUMAN, Ly-72, M-CSF Receptor, M-CSF-R, MGC126514, MGC138170, MGC141919, MGC164568, MGC164570, Macrophage colony stimulating factor I receptor, Macrophage colony-stimulating factor 1 receptor, McDonough feline sarcoma viral (v fms) oncogene homolog, OTTHUMP0000004234, OTTHUMP00000043364, OTTHUMP00000043365, Oncogen FMS, PKC 0, PRKCT, Prkcq, Protein kinase C theta, Protein kinase C theta type, Proto-oncogene c-Fms, Receptor type tyrosine protein kinase FLT3, STK-1, Stem cell tyrosine kinase 1, Tyrosine-protein kinase receptor FLT3, V-FMS McDonough feline sarcoma viral oncogen homolog, formerly, nPKC-theta

1 이미지
Chemical Structure - Pexidartinib, CSF1R inhibitor (AB254454)
  • Chemical Structure

Supplier Data

Chemical Structure - Pexidartinib, CSF1R inhibitor (AB254454)

2D chemical structure image of ab254454, Pexidartinib, CSF1R inhibitor

주요 정보

CAS 번호

1029044-16-3

Purity

>98%

제형

Solid

form

Molecular weight

417.8 Da

Molecular formula

C<sub>2</sub><sub>0</sub>H<sub>1</sub><sub>5</sub>ClF<sub>3</sub>N<sub>5</sub>

PubChem

25151352

Nature

Synthetic

Solubility

Soluble in DMSO to 10 mM

생화학적 명칭

Pexidartinib

생물학적 정보

Potent MCSF Receptor (CSF1R) inhibitor (IC50 = 13 nM). Also inhibits Kit (IC50 = 16 nM) and Flt3 (IC50 = 160 nM). Highly selective (IC50 >1 μM) against a panel of over 200 kinases. Inhibits MCSF Receptor-dependent proliferation (0.1 - 0.44 μM) in cell models. Inhibits glioblastoma invasion in mouse xenograft models.

Canonical SMILES

C1=CC(=NC=C1CC2=CNC3=C2C=C(C=N3)Cl)NCC4=CN=C(C=C4)C(F)(F)F

InChi

InChI=1S/C20H15ClF3N5/c21-15-6-16-14(10-28-19(16)29-11-15)5-12-2-4-18(26-7-12)27-9-13-1-3-17(25-8-13)20(22,23)24/h1-4,6-8,10-11H,5,9H2,(H,26,27)(H,28,29)

InChiKey

JGWRKYUXBBNENE-UHFFFAOYSA-N

IUPAC Name

5-[(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)methyl]-N-[[6-(trifluoromethyl)pyridin-3-yl]methyl]pyridin-2-amine

제품 세부 정보

Solutions in DMSO may be stored at -20°C for up to 2 months.

특성 및 보관 정보

배송 시 보관 조건
Ambient - Can Ship with Ice
적절한 단기 보관 조건
-20°C
적절한 장기 보관 조건
-20°C
보관 정보
Store under desiccating conditions
취급 방법

Need more advice on solubility, usage and handling? Please visit our our product support page for more details.

|

Refer to SDS for further information.

추가 정보

This supplementary information is collated from multiple sources and compiled automatically.

Protein Kinase C theta (PKCθ/PRKCQ) CSF-1-R (colony stimulating factor 1 receptor) and Flt3/CD135 are involved in various cellular functions. PKCθ with a mass of approximately 82 kDa primarily expresses in T cells and is important for T-cell receptor signaling. CSF-1-R also referred to as macrophage colony-stimulating factor receptor (M-CSFR) has a mass of about 120 kDa and expresses in macrophages and osteoclast precursors. Flt3 alternatively known as CD135 weighs around 158 kDa and is predominantly found in hematopoietic progenitor cells. These proteins perform unique mechanical roles integral to cellular processes.
Biological function summary

PKCθ functions in T-cell activation and survival acting as part of a larger signaling complex during immune responses. CSF-1-R is responsible for macrophage proliferation differentiation and survival. It forms a receptor complex upon binding its ligand contributing to tissue homeostasis and inflammation response. Flt3 plays a pivotal role in hematopoiesis especially in the development and maintenance of multipotent progenitor cells. These activities highlight the essential roles each target plays in maintaining immune and hematopoietic systems.

Pathways

PKCθ participates in the NF-kB and AP-1 pathways important for T-cell activation and cytokine production. It signalizes alongside proteins like LAT and SLP-76. CSF-1-R involves in the PI3K-Akt and MAPK/ERK pathways important for cell growth and survival. It interacts with proteins such as Grb2 and Src to propagate its signaling. Flt3 functions in the JAK-STAT and PI3K pathways important for gene expression and cell cycle regulation and associates with STAT5 and Akt proteins. These interactions place these targets within critical cellular communication networks.

PKCθ links to autoimmune diseases like rheumatoid arthritis due to its role in T-cell signaling and activation. It directly influences the production of inflammatory cytokines contributing to disease pathology. CSF-1-R relates to cancer and inflammatory disorders as its dysregulation can lead to tumor growth and chronic inflammation. Pexidartinib acts as a CSF-1-R inhibitor offering therapeutic potential in conditions like tenosynovial giant cell tumors. Flt3 mutations associate with acute myeloid leukemia where its overactivation leads to uncontrolled cell growth. Flt3’s connection to STAT5 indicates its contribution to leukemogenesis.

제품 프로토콜

Product promise

저희는 고품질 시약으로 고객님의 연구를 서포트하고자 최선을 다하고 있으며, 모든 단계에서 함께 하겠습니다. 만약 제품이 기대한 성능을 보이지 않을 경우에도 Product Promise로 보호받으실 수 있습니다.
자세한 내용은 이용 약관을 확인해 주세요.

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com